stockrowAllogene Therapeutics, Inc. (ALLO) vs C4 Therapeutics, Inc. (CCCC)
- Allogene Therapeutics, Inc. ALLO 1.04 −4.59%
- C4 Therapeutics, Inc. CCCC 3.12 +5.76%
Allogene Therapeutics, Inc. and C4 Therapeutics, Inc. are both Biotechnology companies. Allogene Therapeutics, Inc. and C4 Therapeutics, Inc. are of similar size ($376.6M and $362.9M). Allogene Therapeutics, Inc. grew revenue faster over the last twelve months: 7,613.1% against 7.20%. C4 Therapeutics, Inc. has the higher net margin (−282.2% vs −3,517.4%) and the lower return on invested capital (−280.0% vs −108.8%). Across the 15 metrics below, Allogene Therapeutics, Inc. leads on 8 and C4 Therapeutics, Inc. on 7.
Valuation
Profitability
| Metric | ALLO | CCCC | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 68.51% |
| Operating margin | (3,832.45%) | (315.86%) | 0.00% |
| Net margin | (3,517.41%) | (282.22%) | 0.00% |
| Free cash flow margin | (2,180.62%) | (246.71%) | 0.00% |
| Return on equity | (42.39%) | (47.62%) | (51.96%) |
| Return on assets | (32.43%) | (30.50%) | (46.06%) |
| Return on invested capital | (108.81%) | (279.99%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack